Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 2
1960 1
1961 6
1962 2
1963 4
1964 4
1965 1
1966 2
1967 4
1968 3
1969 4
1970 2
1971 2
1972 4
1973 5
1974 6
1975 4
1976 3
1977 3
1980 4
1981 2
1982 3
1983 1
1984 2
1985 5
1986 6
1987 6
1988 2
1989 15
1990 6
1991 13
1992 10
1993 8
1994 10
1995 14
1996 9
1997 7
1998 13
1999 17
2000 10
2001 10
2002 12
2003 9
2004 15
2005 10
2006 10
2007 5
2008 7
2009 5
2010 6
2011 7
2012 6
2013 12
2014 10
2015 8
2016 11
2017 9
2018 7
2019 12
2020 15
2021 19
2022 20
2023 23
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

451 results

Results by year

Filters applied: . Clear all
Page 1
Delayed COVID-19 vaccine roll-out in Japan.
Kosaka M, Hashimoto T, Ozaki A, Tanimoto T, Kami M. Kosaka M, et al. Lancet. 2021 Jun 19;397(10292):2334-2335. doi: 10.1016/S0140-6736(21)01220-4. Epub 2021 Jun 2. Lancet. 2021. PMID: 34089658 Free PMC article. No abstract available.
Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
Yano S, Kawaoka T, Yamasaki S, Johira Y, Kosaka M, Shirane Y, Miura R, Amioka K, Naruto K, Yamaoka K, Fujii Y, Uchikawa S, Fujino H, Ono A, Nakahara T, Murakami E, Miki D, Tsuge M, Teraoka Y, Kouno H, Takaki S, Mori N, Tsuji K, Oka S. Yano S, et al. Among authors: kosaka m. Cancers (Basel). 2023 Nov 14;15(22):5406. doi: 10.3390/cancers15225406. Cancers (Basel). 2023. PMID: 38001666 Free PMC article.
[Immunoglobulin abnormalities].
Kosaka M, Takishita M. Kosaka M, et al. Nihon Naika Gakkai Zasshi. 1995 Jul 10;84(7):1061-9. Nihon Naika Gakkai Zasshi. 1995. PMID: 7561359 Review. Japanese. No abstract available.
Risk Factors for Early Onset of Proteinuria in Patients Receiving Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
Ando Y, Kawaoka T, Kosaka M, Shirane Y, Johira Y, Miura R, Murakami S, Yano S, Amioka K, Naruto K, Kosaka Y, Uchikawa S, Kodama K, Fujino H, Nakahara T, Ono A, Murakami E, Yamauchi M, Okamoto W, Takahashi S, Imamura M, Aikata H. Ando Y, et al. Among authors: kosaka m. Liver Cancer. 2022 Nov 29;12(3):251-261. doi: 10.1159/000528145. eCollection 2023 Aug. Liver Cancer. 2022. PMID: 37601981 Free PMC article.
[Phenylketonuria].
Kosaka M. Kosaka M. Nihon Rinsho. 1967 Oct;25(8):1552-61. Nihon Rinsho. 1967. PMID: 4871752 Review. Japanese. No abstract available.
The Analysis of Muscle Volume Measured by Bioelectrical Impedance in Patients with Hepatocellular Carcinoma Treated with First-Line Atezolizumab plus Bevacizumab Combination Therapy or First-Line Lenvatinib.
Chihiro K, Kawaoka T, Uchikawa S, Kinami T, Yamasaki S, Kosaka M, Johira Y, Yano S, Amioka K, Naruto K, Ando Y, Yamaoka K, Teraoka Y, Uchida T, Fujino H, Nakahara T, Ono A, Murakami E, Okamoto W, Yamauchi M, Miki D, Tsuge M, Imamura M, Aikata H, Oka S. Chihiro K, et al. Among authors: kosaka m. Oncology. 2023;101(8):491-501. doi: 10.1159/000530991. Epub 2023 Jul 10. Oncology. 2023. PMID: 37429266
Evaluation of Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma Using the Combination of Response Evaluation Criteria in Solid Tumors and Alpha-Fetoprotein.
Kinami T, Amioka K, Kawaoka T, Uchikawa S, Yamasaki S, Kosaka M, Johira Y, Yano S, Naruto K, Ando Y, Yamaoka K, Fujii Y, Fujino H, Nakahara T, Ono A, Murakami E, Okamoto W, Yamauchi M, Miki D, Tsuge M, Imamura M, Aikata H, Oka S. Kinami T, et al. Among authors: kosaka m. Cancers (Basel). 2023 Apr 14;15(8):2304. doi: 10.3390/cancers15082304. Cancers (Basel). 2023. PMID: 37190231 Free PMC article.
451 results